Cubist Systematic Strategies’s Nurix Therapeutics NRIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-117,615
| Closed | -$1.4M | – | 2076 |
|
|
2025
Q1 | $1.4M | Sell |
117,615
-6,410
| -5% | -$76.2K | 0.01% | 792 |
|
|
2024
Q4 | $2.34M | Buy |
+124,025
| New | +$2.34M | 0.01% | 553 |
|
|
2024
Q2 | – | Sell |
-36,256
| Closed | -$533K | – | 2253 |
|
|
2024
Q1 | $533K | Buy |
+36,256
| New | +$533K | ﹤0.01% | 1365 |
|
|
2023
Q4 | – | Sell |
-9,830
| Closed | -$77.3K | – | 2490 |
|
|
2023
Q3 | $77.3K | Sell |
9,830
-32,722
| -77% | -$257K | ﹤0.01% | 1659 |
|
|
2023
Q2 | $425K | Buy |
42,552
+17,863
| +72% | +$178K | ﹤0.01% | 1464 |
|
|
2023
Q1 | $219K | Buy |
+24,689
| New | +$219K | ﹤0.01% | 2175 |
|
|
2022
Q4 | – | Sell |
-131,919
| Closed | -$1.72M | – | 3484 |
|
|
2022
Q3 | $1.72M | Buy |
131,919
+63,235
| +92% | +$824K | 0.01% | 1703 |
|
|
2022
Q2 | $870K | Buy |
68,684
+9,103
| +15% | +$115K | 0.01% | 2206 |
|
|
2022
Q1 | $835K | Buy |
59,581
+44,567
| +297% | +$625K | 0.01% | 2175 |
|
|
2021
Q4 | $435K | Buy |
+15,014
| New | +$435K | ﹤0.01% | 2543 |
|
|
2021
Q3 | – | Sell |
-12,663
| Closed | -$336K | – | 3113 |
|
|
2021
Q2 | $336K | Buy |
12,663
+4,463
| +54% | +$118K | ﹤0.01% | 2261 |
|
|
2021
Q1 | $255K | Buy |
+8,200
| New | +$255K | ﹤0.01% | 2347 |
|